A Retrospective Study on Lymphadenectomy in Minimally Invasive Surgery for Early-Stage Endometrial Cancer at Our Institution
The revised 2023 guidelines for endometrial cancer treatment recommend avoiding lymphadenectomy in early-stage cases (evidence level C). However, some patients initially diagnosed with early-stage cancer are later classified as intermediate or high risk after surgery and pathological evaluation. While pelvic lymphadenectomy remains critical for pathological assessment, its necessity and extent should be tailored to each patient based on therapeutic relevance.
Authors
- Kohei Yamaguchi (ORCID: https://orcid.org/0000-0003-0388-3411)
- Yasushi Hirota (ORCID: https://orcid.org/0000-0003-0241-9780)
- Yutaka Osuga (ORCID: https://orcid.org/0000-0002-6660-1066)
- Eri Suzuki
- Satoko Eguchi (ORCID: https://orcid.org/0009-0008-9861-2393)
- Kenbun Sone
- Yuichiro Miyamoto
- Harunori Honjoh (ORCID: https://orcid.org/0009-0004-3953-6010)
- Yoshiko Kawata
- Mayuyo Mori
Institutions
- University of Tokyo Hospital (JP)
Publication Details
- Journal
- JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5180/jsgoe.41.1_49
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00